Los Angeles, CA, United States of America

Robert Peter Gale

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Ziopharm Oncology, Inc.. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert Peter Gale. Retrieved from https://idiyas.com/inventor/robert-peter-gale

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Robert Peter Gale

Introduction

Robert Peter Gale is a notable inventor based in Los Angeles, CA. He has made significant contributions to the field of oncology through his innovative research and development of anti-tumor agents. His work has the potential to impact the treatment of hyperproliferative disorders.

Latest Patents

Gale holds a patent for "Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents." This patent relates to salts and compositions of isophosphoramide mustard and its analogs. The disclosed compounds can be represented by a specific formula involving ammonium species and various leaving groups. The patent also outlines methods for making these compounds and formulating pharmaceutical compositions. Furthermore, it details methods for administering these compounds to treat hyperproliferative disorders.

Career Highlights

Robert Peter Gale is associated with Ziopharm Oncology, Inc., where he continues to advance his research in oncology. His work focuses on developing innovative treatments that can improve patient outcomes in cancer therapy.

Conclusion

Robert Peter Gale's contributions to the field of oncology through his patent and work at Ziopharm Oncology, Inc. highlight his commitment to advancing medical science. His innovations in anti-tumor agents represent a significant step forward in cancer treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…